MS
McCarthy Sean A.
Chief Executive Officer
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by McCarthy Sean A., Chief Executive Officer. Insider active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 23 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €1.7m. Activity tracked since 30 September 2019. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McCarthy Sean A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
118,969 shares@ US$6.42339.7% of flowCommon StockSEC:0001610717-26-000124:0
210,000 shares0Common StockSEC:0001610717-26-000039:0
101,793 shares@ US$4.537719.4% of flowClass A Common StockSEC:0001610717-25-000372:0
150,000 shares0Common StockSEC:0001610717-25-000234:0
37,656 shares@ US$0.5991.2% of flowCommon StockSEC:0001610717-25-000086:0
180,000 shares0Common StockSEC:0001610717-25-000016:0
37,500 shares0Common StockSEC:0001610717-24-000432:0
109,768 shares@ US$1.57499.5% of flowCommon StockSEC:0001610717-24-000190:0
20,223 shares@ US$2.08552.3% of flowCommon StockSEC:0001610717-24-000178:0
90,000 shares0Common StockSEC:0001610717-24-000036:0
13,551 shares@ US$1.38071.0% of flowCommon StockSEC:0001610717-23-000423:0
37,500 shares0Common StockSEC:0001610717-23-000411:0
40,000 shares0Common StockSEC:0001610717-23-000297:0
16,535 shares@ US$1.57491.4% of flowCommon StockSEC:0001610717-23-000061:0
7,121 shares@ US$1.88050.8% of flowCommon StockSEC:0001140361-23-012618:0
105,000 shares0Common StockSEC:0001567619-23-001930:0
40,000 shares0Common StockSEC:0001567619-22-014299:0
66,742 shares@ US$0.9450.0082% mcap4.2% of flowCommon StockSEC:0001567619-22-010091:0
75,000 shares0Common StockSEC:0001567619-22-002521:0
92,113 shares@ US$1.13394.3% of flowCommon StockSEC:0001567619-21-015554:0
100,000 shares@ US$7.044728.3% of flowCommon StockSEC:0001567619-21-012419:0
30 shares@ US$1.13390.0% of flowCommon StockSEC:0001567619-21-012252:0
4,500 shares0Common StockSEC:0001567619-21-011808:0
About McCarthy Sean A.
Sean A. McCarthy is President and Chief Executive Officer at CytomX Therapeutics, Inc. He has filed 23 disclosures in total, and across the sampled recent filings from 2021-06-08 to 2026-03-19, sales total EUR 1742673 and the most frequent transaction nature is Option exercise.